# India Extracorporeal Membrane Oxygenation Machine Market > India Extracorporeal Membrane Oxygenation Machine Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) andBy Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.89% - **2024:** $ 93.18 Million - **2025:** $ 98.67 Million - **2035:** $ 174.88 Million - **Key Players:** Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) **Report ID:** MRFR/HC/49077-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-extracorporeal-membrane-oxygenation-machine-market-50834 --- ## Market Summary ## **India Extracorporeal Membrane Oxygenation Machine Market Overview** As per MRFR analysis, the India Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 88 (USD Million) in 2023. The India Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 120(USD Million) in 2024 to 240 (USD Million) by 2035. The India Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035). ### **Key India Extracorporeal Membrane Oxygenation Machine Market Trends Highlighted** The India Extracorporeal Membrane Oxygenation Machine Market is experiencing notable market trends driven by an increasing prevalence of respiratory and cardiac conditions. As more patients require advanced life-support systems, healthcare providers are investing in ECMO machines to enhance patient outcomes. Government initiatives aimed at improving healthcare infrastructure, especially in critical care, further support this growth. Facilities across India are looking to upgrade their medical equipment to meet international standards, which bolsters the demand for innovative ECMO technology. Opportunities to be explored include the potential for partnerships between local manufacturers and international companies to develop cost-effective ECMO solutions tailored for the Indian market. The Indian healthcare system is transitioning to home and community health models, which has opened up new opportunities for portable ECMO units. Additionally, the increasing emphasis on telemedicine presents an opportunity for remote monitoring solutions, which will improve the ECMO treatment process. A growing awareness among healthcare professionals regarding the advantages of ECMO has resulted in an increase in the number of training programs and certification courses. Recent trends reflect this trend. The increasing prevalence of advanced ECMO systems in India is facilitating the accessibility of these instruments to healthcare providers by providing improved user interfaces and automated functions. Furthermore, there is a growing emphasis on the integration of artificial intelligence and miniaturisation, which has the potential to transform patient care in critical situations. The ECMO market in India is poised to undergo a transformation as a result of this transition to more advanced technology and innovative practices. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **India Extracorporeal Membrane Oxygenation Machine Market Drivers** #### **Increasing Incidence of Respiratory Diseases in India** The rise in respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and pneumonia due to air pollution and changing lifestyle is a significant driver for the India Extracorporeal Membrane Oxygenation Machine Market Industry. According to the Ministry of Health and Family Welfare in India, about 10% of the population suffers from various forms of respiratory ailments. This alarming statistic translates to approximately 136 million individuals in need of advanced respiratory support, including Extracorporeal Membrane Oxygenation machines. Leading healthcare provider organizations, like Apollo Hospitals, are investing in advanced medical technologies, including ECMO machines, to cater to this rising demand, thereby propelling market growth. This trend is expected to expand as India's healthcare infrastructure continues to improve and modernize to meet the populace's requirements. #### **Government Initiatives to Improve Healthcare Access** The Indian government's ongoing efforts to enhance healthcare infrastructure significantly contribute to the growth of the India Extracorporeal Membrane Oxygenation Machine Market Industry. Initiatives such as the Ayushman Bharat scheme target improving healthcare access for over 500 million citizens by providing financial support for hospital treatments. As a result, hospitals are increasingly equipped with sophisticated technologies, including ECMO systems, to improve critical care services. According to the National Health Authority, there has been a notable increase in funding and resources allocated to critical care units across the country, which has directly influenced the adoption of advanced medical devices like ECMO machines. These initiatives serve to bolster the healthcare sector and address the increasing cases of severe respiratory conditions, driving market growth. #### **Rising Number of Cardiac Cases Requiring Advanced Techniques** The growing prevalence of cardiovascular diseases (CVD) in India is another vital driver for the India Extracorporeal Membrane Oxygenation Machine Market Industry. Research from the Indian Heart Association indicates that cardiovascular diseases account for nearly 30% of deaths in India, amounting to approximately 1.5 million fatalities annually. This rampant increase necessitates innovative treatment options, including Extracorporeal Membrane Oxygenation, to improve survival rates in severe cases. Major players like Fortis Healthcare are actively investing in ECMO technologies as a part of their advanced treatment protocols for cardiac patients. As the incidence of cardiac diseases rises, hospitals are likely to expand ECMO availability, directly influencing market growth. #### **Technological Advancements in ECMO Systems** Rapid technological advancements in Extracorporeal Membrane Oxygenation systems are propelling demand in the India Extracorporeal Membrane Oxygenation Machine Market Industry. Innovations such as miniaturized ECMO systems and improved biocompatibility materials are enhancing performance and user-friendliness. These improvements are crucial in a country with diverse healthcare facilities, granting access to critical care even in smaller hospitals. According to the healthcare technology assessment guidelines issued by the Indian Medical Association, there is a growing demand for cutting-edge medical devices that combine performance with efficiency. Enhanced ECMO technologies help meet this growing demand, resulting in increased adoption as healthcare providers recognize their importance in treating critical patients. ### **India Extracorporeal Membrane Oxygenation Machine Market Segment Insights** #### **Extracorporeal Membrane Oxygenation Machine Market Application Insights** The India Extracorporeal Membrane Oxygenation Machine Market demonstrates a robust Application segment, which plays a pivotal role in critical care settings across the country. This market is primarily categorized into three major areas Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass. Cardiac Support is instrumental in providing life-saving therapy for patients suffering from severe cardiac issues, allowing for extended time for recovery and evaluation of other treatment options. In India, the increased prevalence of cardiovascular diseases contributes significantly to the demand for advanced cardiac care technologies, making this application not only vital but also one of the predominant drivers of market growth. Respiratory Support is another critical facet of this market, particularly with rising respiratory diseases, complications from the COVID-19 pandemic, and other viral infections impacting lung function. The effectiveness of Extracorporeal Membrane Oxygenation machines in providing adequate oxygenation and carbon dioxide removal is a game changer, emphasizing its importance in emergency and intensive care units within India's healthcare framework. The advancement in technologies related to Respiratory Support often leads to improved patient outcomes, ensuring a notable presence in the overarching market. Cardiopulmonary Bypass, while less frequently discussed, plays an essential role during surgical procedures, especially in cardiac surgeries. The ability of these machines to temporarily take over the function of the heart and lungs allows surgeons to conduct intricate procedures with enhanced safety. As India continues to escalate its healthcare infrastructure, the demand for reliable and efficient Cardiopulmonary Bypass systems will undoubtedly rise, thereby reinforcing the significance of this application within the India Extracorporeal Membrane Oxygenation Machine Market. Overall, these applications collectively underline the strategic importance and operational effectiveness of Extracorporeal Membrane Oxygenation Machines in treating life-threatening conditions, particularly within India. The growing healthcare investments, increasing awareness of advanced treatment modalities, and rising patient volumes are solidifying the market's potential across these crucial areas of application. As the dynamics of the healthcare sector continue to evolve, the integration and advancement of ECMO technology stand to greatly enhance the quality of cardiovascular and respiratory care available to patients. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review #### **Extracorporeal Membrane Oxygenation Machine Market End User Insights** The India Extracorporeal Membrane Oxygenation Machine Market is largely driven by its applications in various end-user settings, including hospitals, ambulatory surgical centers, and home care settings. Hospitals are often the primary users due to their capacity to handle critical care patients, providing advanced respiratory support for those with severe heart and lung issues. Ambulatory surgical centers play a significant role by facilitating quicker surgical procedures that require immediate post-operative support, thereby enhancing patient recovery times. Additionally, home care settings are gaining prominence, allowing patients with chronic respiratory problems to receive effective treatment in a comfortable environment, which aligns with the Indian government's initiatives to promote home healthcare services. The increasing prevalence of cardiovascular diseases and respiratory disorders in India is a critical growth driver, amplifying the demand for extracorporeal membrane oxygenation machines across these sectors. This combined interest reflects a positive trajectory in the India Extracorporeal Membrane Oxygenation Machine Market as it adapts to the evolving healthcare landscape. Each setting contributes uniquely to the overall landscape, catering to a diverse patient population with specific needs. #### **Extracorporeal Membrane Oxygenation Machine Market Product Type Insights** The India Extracorporeal Membrane Oxygenation Machine Market exhibits a diverse range of product types, notably encompassing Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO. Venoarterial ECMO is primarily utilized in critical care settings for patients experiencing severe cardiac and respiratory failure, highlighting its significance in life-saving scenarios. This form of ECMO provides both cardiac and respiratory support, thereby dominating emergency care protocols in India, where the prevalence of cardiovascular diseases is on the rise. Venovenous ECMO, on the other hand, is particularly effective for patients suffering from severe respiratory failure, allowing for oxygenation without the need for full cardiac support. This type of ECMO is increasingly recognized for its role in treating conditions like COVID-19-related acute respiratory distress syndrome (ARDS) in Indian hospitals. Arteriovenous ECMO serves a more niche role, often used in specialized situations such as for patients needing both hemodialysis and respiratory support. As the demand for advanced medical technologies grows, particularly in urban centers, understanding these product types is essential for healthcare professionals and policymakers in enhancing patient outcomes within the India Extracorporeal Membrane Oxygenation Machine Market. Moreover, the increasing number of ECMO-trained personnel and facilities will likely drive further adoption of these technologies, reflecting the market's growth potential. #### **Extracorporeal Membrane Oxygenation Machine Market Component Insights** The Component segment of the India Extracorporeal Membrane Oxygenation Machine Market encompasses critical elements such as Membrane Oxygenators, Blood Pumps, and Heat Exchangers, which collectively play a vital role in the functionality and efficiency of ECMO systems. Membrane Oxygenators are essential for gas exchange, enabling oxygenation of blood while removing carbon dioxide, thus supporting patients with severe cardiac or respiratory failure. Blood Pumps are significant as they maintain circulation and ensure effective blood flow, which is crucial during long-term procedures. Heat Exchangers, on the other hand, regulate blood temperature, thereby preventing hypothermia and optimizing patient outcomes. The demand for sophisticated components has surged with the increasing prevalence of chronic diseases and the need for advanced medical technologies in India. As the healthcare infrastructure expands and evolves, driven by government initiatives aimed at improving health services, these components are positioned to dominate the market. The ongoing advancements in materials and technology highlight the importance of innovation in this segment, paving the way for enhanced performance and patient care in critical situations. With a focus on high-quality components, the India Extracorporeal Membrane Oxygenation Machine Market is expected to thrive, reflecting the growing emphasis on specialized medical treatments in the country. ### **India Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights** The India Extracorporeal Membrane Oxygenation Machine Market has been witnessing significant growth driven by various factors such as the increasing prevalence of respiratory diseases, advancements in healthcare technologies, and a rising number of cardiac surgeries. The competitive landscape of this market is characterized by both national and international players striving to innovate and expand their offerings to cater to the growing demand for ECMO machines. Understanding the competitive dynamics is vital for stakeholders aiming to identify opportunities and mitigate challenges as the market evolves. Companies are focusing on enhancing product features, reliability, and efficiency while also establishing strategic alliances and partnerships to broaden their market reach and improve patient outcomes. Asahi Kasei Medical has established a notable presence in the India Extracorporeal Membrane Oxygenation Machine Market through its commitment to quality and innovation. The company is well-regarded for its comprehensive range of ECMO products, which are designed to meet the stringent requirements of healthcare providers. Key strengths of Asahi Kasei Medical include its strong research and development capabilities that drive the continuous improvement of its products, ensuring they align with the latest medical standards and technological advancements. Moreover, the company benefits from its established supply chain and distribution networks within India, enabling it to effectively serve hospitals and healthcare facilities across various regions. This strategic positioning allows Asahi Kasei Medical to maintain a competitive edge in the market, addressing the increasing demands for better respiratory support systems. LivaNova has also made significant strides in the India Extracorporeal Membrane Oxygenation Machine Market, positioning itself as a key player in providing advanced medical solutions. The company offers a range of ECMO devices that are known for their cutting-edge technology and reliability, which are essential for critical care patients. LivaNova's strengths lie in its innovative product lines, robust clinical support, and effective marketing strategies, which continue to solidify its market position. The company has engaged in strategic mergers and acquisitions to bolster its product offerings and expand its footprint in the Indian market. Through these endeavors, LivaNova aims to enhance its service delivery to healthcare providers, ensuring they have access to state-of-the-art ECMO solutions that facilitate improved patient outcomes in a critical care setting. #### **Key Companies in the India Extracorporeal Membrane Oxygenation Machine Market Include** - Asahi Kasei Medical - LivaNova - Medtronic - Nihon Kohden Corporation - Fresenius Medical Care - Cleveland Medical Devices - Glenmed - CardioMed - Terumo Corporation - Mediwar - Xenios AG - Jiangsu Tiansheng Medical Devices - Mediatrix - Nipro Corporation - Getinge ### **India Extracorporeal Membrane Oxygenation Machine Market Industry Developments** In recent developments, the India Extracorporeal Membrane Oxygenation Machine Market has been witnessing a notable increase in demand due to the rising incidence of respiratory illnesses and cardiovascular diseases, particularly in the wake of the COVID-19 pandemic. Asahi Kasei Medical and LivaNova are among the key players enhancing their market presence, while Medtronic and Nihon Kohden Corporation continue to innovate in technology. Current affairs indicate significant growth in market valuation, with several companies, including Fresenius Medical Care and Terumo Corporation, expanding their product offerings and geographical reach to cater to the growing healthcare needs. Notably, in June 2023, Getinge announced a strategic partnership with a leading Indian hospital chain to enhance ECMO treatment capabilities, further solidifying its market position. The competitive landscape is also marked by an acquisition by Jiangsu Tiansheng Medical Devices in July 2023, acquiring a local company to strengthen its foothold in India. This surge in capacity building and strategic collaborations among key players is significantly reshaping the ECMO machine market in India, ensuring better health outcomes for critically ill patients. ### **India Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights** #### **Extracorporeal Membrane Oxygenation Machine Market Application Outlook** - Cardiac Support - Respiratory Support - Cardiopulmonary Bypass #### **Extracorporeal Membrane Oxygenation Machine Market End User Outlook** - Hospitals - Ambulatory Surgical Centers - Home Care Settings #### **Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook** - Venoarterial ECMO - Venovenous ECMO - Arteriovenous ECMO #### **Extracorporeal Membrane Oxygenation Machine Market Component Outlook** - Membrane Oxygenator - Blood Pumps - Heat Exchangers ## Market Drivers ### Rising Geriatric Population India's aging population is a significant factor influencing the extracorporeal membrane-oxygenation-machine market. As the demographic shifts towards an older age group, the incidence of age-related health issues, including cardiovascular and respiratory diseases, is expected to increase. The geriatric population is projected to reach 300 million by 2030, creating a higher demand for advanced medical technologies such as ECMO. This demographic trend indicates that healthcare providers will need to invest in extracorporeal membrane-oxygenation machines to cater to the specific needs of older patients, thereby driving market growth. The focus on improving healthcare services for the elderly population is likely to enhance the adoption of ECMO technology in hospitals. ### Advancements in Medical Infrastructure The ongoing improvements in medical infrastructure across India are propelling the growth of the extracorporeal membrane-oxygenation-machine market. With the establishment of more specialized hospitals and intensive care units (ICUs), there is a growing need for advanced life-support technologies. Investments in healthcare facilities have increased, with the government and private sectors focusing on enhancing critical care services. Reports indicate that the healthcare expenditure in India is projected to reach approximately $370 billion by 2025, which could lead to a higher adoption rate of ECMO machines. This trend suggests that as hospitals upgrade their equipment, the demand for extracorporeal membrane-oxygenation machines will likely rise, reflecting a shift towards more sophisticated medical care. ### Increased Focus on Critical Care Training The heightened emphasis on critical care training for healthcare professionals is influencing the extracorporeal membrane-oxygenation-machine market. As medical education evolves, there is a growing recognition of the need for specialized training in the use of advanced life-support systems, including ECMO. Institutions are increasingly incorporating ECMO training into their curricula, which is expected to improve the proficiency of healthcare providers in managing complex cases. This focus on education and training may lead to a more widespread adoption of extracorporeal membrane-oxygenation machines in hospitals, as trained professionals will be better equipped to utilize this technology effectively. Consequently, the market is likely to benefit from a more skilled workforce capable of delivering high-quality critical care. ### Growing Investment in Healthcare Technology The increasing investment in healthcare technology in India is a pivotal driver for the extracorporeal membrane-oxygenation-machine market. With both public and private sectors recognizing the importance of advanced medical equipment, funding for healthcare innovation is on the rise. The Indian government has initiated various schemes to promote healthcare technology, which includes the procurement of ECMO machines. Reports suggest that the healthcare technology market in India is expected to grow at a CAGR of around 25% over the next few years. This influx of capital into healthcare technology is likely to facilitate the acquisition of extracorporeal membrane-oxygenation machines, thereby enhancing the capabilities of medical facilities to provide critical care. ### Increasing Incidence of Respiratory Diseases The rising prevalence of respiratory diseases in India is a crucial driver for the extracorporeal membrane-oxygenation-machine market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia are becoming more common, necessitating advanced medical interventions. According to health statistics, respiratory diseases account for a significant portion of hospital admissions, leading to an increased demand for extracorporeal membrane oxygenation (ECMO) machines. This trend is likely to continue as urbanization and pollution levels rise, further exacerbating respiratory health issues. The extracorporeal membrane-oxygenation-machine market is expected to expand as healthcare facilities seek to enhance their capabilities in managing severe respiratory conditions, thereby improving patient outcomes. ## Future Outlook The [Extracorporeal Membrane Oxygenation Machine Market](https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119) is projected to grow at a 5.89% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of portable ECMO systems for emergency medical services Expansion of telemedicine integration for remote monitoring Partnerships with hospitals for ECMO training programs By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Application: Cardiac Support (Largest) vs. Respiratory Support (Fastest-Growing) In the India extracorporeal membrane-oxygenation-machine market, the application segment shows a diverse distribution among its key values. Cardiac Support holds the largest market share due to its critical role in treating patients with severe cardiac conditions. This segment benefits from an established infrastructure in healthcare facilities and a growing awareness of advanced cardiac treatments. On the other hand, Respiratory Support is emerging rapidly as a crucial service, especially with rising respiratory ailments, making it a vital player in the sector. Analysis of growth trends indicates a significant uptick in demand for both Cardiac and Respiratory Support applications. The rising prevalence of heart diseases and respiratory disorders in the country has prompted healthcare providers to adopt extracorporeal membrane oxygenation machines extensively. Government initiatives enhancing healthcare access and technological advancements in ECMO technologies are driving this growth, forming a robust foundation for future expansion within this segment. Cardiac Support (Dominant) vs. Respiratory Support (Emerging) Cardiac Support stands out as the dominant application in the India extracorporeal membrane-oxygenation-machine market, characterized by its extensive usage in critical care environments where stabilization of patients with severe cardiovascular issues is necessary. This segment is well-integrated into existing medical frameworks, aiding in post-operative recovery and management of complex cases. Conversely, Respiratory Support is an emerging application gaining traction, particularly in light of increasing respiratory health challenges, including COVID-19, which has created urgent needs for advanced respiratory assistance. This segment is witnessing rapid technological innovations, leading to improved patient outcomes and a higher adoption rate in both hospitals and specialized care units. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the India extracorporeal membrane-oxygenation-machine market, hospitals represent the largest segment, capturing a significant portion of the overall usage. This dominance is attributed to the extensive infrastructure and resources hospitals have for ECMO procedures. On the other hand, ambulatory surgical centers are gaining traction, primarily due to their ability to provide specialized services with lower operational costs, making them an attractive choice for both patients and healthcare providers. The growth trends within this segment indicate a shift towards more decentralized healthcare delivery. Ambulatory surgical centers are recognized for their efficiency and have seen increased investments which facilitate faster access to ECMO services. Furthermore, home care settings are gradually emerging, driven by technological advancements that allow for safe and effective at-home ECMO management, albeit at a slower growth rate compared to the other segments. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals play a dominant role in the India extracorporeal membrane-oxygenation-machine market, providing a comprehensive range of services owing to their advanced technology and skilled personnel. They cater to critically ill patients requiring ECMO support, thus driving substantial demand for this life-saving equipment. Conversely, ambulatory surgical centers represent an emerging segment, characterized by streamlined patient care and lower costs. These facilities are designed to perform specific procedures efficiently, making ECMO services more accessible. Despite their smaller market share compared to hospitals, their rapid growth is fueled by increasing healthcare consumerism and a shift towards outpatient care models, positioning them as a vital part of the evolving healthcare landscape. ### By Product Type: Venoarterial ECMO (Largest) vs. Venovenous ECMO (Fastest-Growing) In the India extracorporeal membrane-oxygenation-machine market, the Venoarterial ECMO segment holds a significant share, making it the dominant product type. This segment caters to a wide range of critical care scenarios, particularly in cardiac support, leading to its prevalence in healthcare settings. Conversely, the Venovenous ECMO segment, while currently smaller in market share, is experiencing rapid growth as the demand for respiratory support solutions increases, particularly in the context of severe respiratory distress syndromes. Growth trends in this segment are primarily driven by advancements in technology and increasing awareness of ECMO's effectiveness in critical care. Factors such as rising incidences of cardiac and respiratory failure, along with improved healthcare infrastructure, are contributing to the uptake of both Venoarterial and Venovenous ECMO systems. The latter is especially poised for growth as medical professionals seek more versatile and effective solutions for patient management in intensive care units, showcasing its potential to reshape treatment approaches. Venoarterial ECMO (Dominant) vs. Venovenous ECMO (Emerging) The Venoarterial ECMO segment is currently the dominant force within the India extracorporeal membrane-oxygenation-machine market, primarily due to its extensive applications in cardiac support. It provides critical life-saving interventions for patients experiencing severe cardiac disruptions. In contrast, the Venovenous ECMO segment is emerging as a key player, gaining traction due to its utility in providing comprehensive cardiopulmonary support for patients suffering from respiratory complications. Both segments highlight a significant evolution in treatment methodologies, with Venoarterial ECMO maintaining a stable foothold, while Venovenous ECMO is rapidly adapting to the growing needs of modern medical practices, positioning it as an essential component in the toolkit of ECMO technologies. ### By Component: Membrane Oxygenator (Largest) vs. Blood Pumps (Fastest-Growing) In the India extracorporeal membrane-oxygenation-machine market, the distribution of market share among the key component segments indicates that membrane oxygenators dominate the landscape due to their crucial role in oxygen transfer. Blood pumps, while not the largest, are rapidly gaining traction, reflecting an increasing reliance on advanced technology in ECMO procedures. Heat exchangers hold a smaller share but remain integral to efficient heat management in ECMO systems. The growth trends in this segment are driven by technological advancements and an increasing prevalence of cardiac and respiratory ailments necessitating ECMO support. The demand for more efficient and reliable membrane oxygenators propels their market position, while blood pumps are witnessing a surge in adoption as healthcare facilities aim to improve patient outcomes with faster, more efficient devices. These evolving needs highlight an overall positive outlook for the segment. Membrane Oxygenator (Dominant) vs. Blood Pumps (Emerging) The membrane oxygenator segment is characterized by its dominance in the India extracorporeal membrane-oxygenation-machine market, primarily due to its essential function in enabling gas exchange during ECMO procedures. This component is recognized for its efficiency and reliability, crucial for critical care settings. In contrast, blood pumps are emerging rapidly; they are gaining popularity because of their advanced designs that offer better flow management and reduced complications. As hospitals increasingly seek to enhance operational efficiency and patient care, these two segments highlight the evolving landscape of ECMO technology, where the dominant role of membrane oxygenators juxtaposes with the innovative growth of blood pumps. ## Competitive Benchmarking The extracorporeal membrane-oxygenation-machine market in India is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are actively enhancing their market positions through various strategic initiatives. Medtronic (US) focuses on technological advancements in ECMO systems, aiming to improve patient outcomes and operational efficiency. Getinge (SE) emphasizes its commitment to sustainability and digital transformation, which appears to resonate well with healthcare providers seeking modern solutions. LivaNova (GB) is leveraging its expertise in cardiac care to expand its ECMO offerings, indicating a strategic alignment with the growing demand for advanced respiratory support systems.The market structure is moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the Indian context. This localization strategy not only enhances operational efficiency but also allows companies to respond more swiftly to regional demands. The collective influence of these major players contributes to a dynamic competitive environment, where innovation and adaptability are paramount. In August Medtronic (US) announced the launch of a new ECMO device designed to enhance patient mobility during treatment. This strategic move is significant as it addresses a critical need for improved patient comfort and mobility, potentially leading to better clinical outcomes. The introduction of this device may also strengthen Medtronic's market position by differentiating its offerings in a competitive landscape. In September Getinge (SE) entered into a partnership with a leading Indian healthcare provider to co-develop ECMO training programs for medical professionals. This collaboration underscores Getinge's commitment to enhancing the skill set of healthcare workers, which is essential for the effective use of advanced ECMO technologies. Such initiatives not only bolster Getinge's reputation but also contribute to the overall growth of the ECMO market in India by ensuring that healthcare providers are well-equipped to utilize these systems. In October LivaNova (GB) expanded its manufacturing capabilities in India, aiming to increase production capacity for its ECMO devices. This strategic expansion is likely to enhance LivaNova's responsiveness to local market demands and reduce lead times for healthcare providers. By investing in local manufacturing, LivaNova positions itself to better serve the Indian market while potentially lowering costs associated with imports. As of November the competitive trends in the extracorporeal membrane-oxygenation-machine market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into healthcare solutions. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and improving patient care. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on technological advancements, supply chain reliability, and innovative solutions that enhance patient outcomes. ## Recent News & Developments In recent developments, the India Extracorporeal Membrane Oxygenation Machine Market has been witnessing a notable increase in demand due to the rising incidence of respiratory illnesses and cardiovascular diseases, particularly in the wake of the COVID-19 pandemic. Asahi Kasei Medical and LivaNova are among the key players enhancing their market presence, while Medtronic and Nihon Kohden Corporation continue to innovate in technology. Current affairs indicate significant growth in market valuation, with several companies, including Fresenius Medical Care and Terumo Corporation, expanding their product offerings and geographical reach to cater to the growing healthcare needs. Notably, in June 2023, Getinge announced a strategic partnership with a leading Indian hospital chain to enhance ECMO treatment capabilities, further solidifying its market position. The competitive landscape is also marked by an acquisition by Jiangsu Tiansheng Medical Devices in July 2023, acquiring a local company to strengthen its foothold in India. This surge in capacity building and strategic collaborations among key players is significantly reshaping the ECMO machine market in India, ensuring better health outcomes for critically ill patients. ## Report Scope | MARKET SIZE 2024 | 93.18(USD Million) | | --- | --- | | MARKET SIZE 2025 | 98.67(USD Million) | | MARKET SIZE 2035 | 174.88(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.89% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) | | Segments Covered | Application, End User, Product Type, Component | | Key Market Opportunities | Advancements in technology and increasing demand for critical care solutions drive growth in the extracorporeal membrane-oxygenation-machine market. | | Key Market Dynamics | Rising demand for advanced extracorporeal membrane-oxygenation machines driven by regulatory support and technological innovations. | | Countries Covered | India | ## Frequently Asked Questions **Q: What was the market valuation of the India extracorporeal membrane-oxygenation-machine market in 2024?** A: The market valuation was $93.18 Million in 2024. **Q: What is the projected market valuation for the India extracorporeal membrane-oxygenation-machine market by 2035?** A: The projected valuation for 2035 is $174.88 Million. **Q: What is the expected CAGR for the India extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 5.89%. **Q: Which application segment had the highest valuation in 2024?** A: The Respiratory Support application segment had the highest valuation at $40.0 Million in 2024. **Q: What are the projected valuations for the Cardiac Support application segment by 2035?** A: The projected valuation for the Cardiac Support application segment is $56.0 Million by 2035. **Q: Which end user segment is expected to grow the most by 2035?** A: The Hospitals end user segment is expected to grow to $75.0 Million by 2035. **Q: What was the valuation of the Venovenous ECMO product type in 2024?** A: The valuation of the Venovenous ECMO product type was $40.0 Million in 2024. **Q: Which component segment is projected to reach $75.0 Million by 2035?** A: The Membrane Oxygenator component segment is projected to reach $75.0 Million by 2035. **Q: Who are the key players in the India extracorporeal membrane-oxygenation-machine market?** A: Key players include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Cleveland Medical Devices. **Q: What is the projected valuation for the Arteriovenous ECMO product type by 2035?** A: The projected valuation for the Arteriovenous ECMO product type is $38.88 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-extracorporeal-membrane-oxygenation-machine-market-50834*